Darmiyan

our first product is brainSee:
fDA-breakthrough, pending approval

BrainSee Is A Medical Device

BrainSee is: clinical software designed to be used as a medical device in the clinical setting to aid in the prognosis of patients who have amnestic mild cognitive impairment (aMCI).

BrainSee is: A novel AI algorithm running in the cloud that processes patient medical data (details below) and gives a score (between 0 and 100%) that reflects the likelihood of progression from mild cognitive impairment to Alzheimer’s dementia within 5 years.